Search results
Alpha-1 Wrestling’s Return Announced For February 2024
Wrestle Zone via Yahoo News· 7 months agoAlpha-1 Wrestling is returning in 2024. In a video on his YouTube channel, Ethan Page announced that...
Ethan Page Announces More Details On The Return Of Alpha-1 Wrestling
Wrestle Zone via Yahoo News· 7 months agoEthan Page has revealed more information on the upcoming return of his independent promotion Alpha-1...
Ethan Page Reveals One Of The Favorite Things He’s Ever Done In His Career
Wrestle Zone via Yahoo News· 5 months agoEthan Page is really excited about relaunching Alpha-1 Wrestling in 2024. All Elite Wrestling’s...
Nothing Phone (1) gets the first taste of Android 13 via Paranoid Android
Android Central via Yahoo News· 2 years agoNothing Phone (1) next to a neon glowing number 13 What you need to know Nothing Phone (1) gets a...
Vertex Moves Its Alpha-1 Antitrypsin Deficiency Program Forward
Benzinga via Yahoo Finance· 2 years agoVertex Pharmaceuticals Inc (NASDAQ: VRTX) has advanced its investigational program targeting alpha-1...
Inhibrx Soared 176% Over Two Months — Now, Sanofi Is Buying It
Investor's Business Daily· 5 months agoSanofi is getting into the liver disease treatment space with its $1.7 billion acquisition of...
Sanofi to buy Inhibrx in deal worth up to $2.2B
BioPharma Dive via Yahoo Finance· 5 months agoThe acquisition will give Sanofi an experimental drug for alpha-1 antitrypsin deficiency, while the rest of Inhibrx's assets will be spun into a new...
A new non-surgical procedure is helping those with emphysema breathe better. The only problem? Not...
USA TODAY via Yahoo News· 2 years agoMILWAUKEE — About two years ago, John McLees' lungs had become so badly damaged that he could barely...
Inhibrx's Experimental Drug For Inherited Disease Capable For Accelerated FDA Approval, Shares Surge
Benzinga via Yahoo Finance· 2 years agoBased on discussions with the FDA, Inhibrx Inc (NASDAQ: INBX) has the potential to pursue...
Arrowhead Pharmaceuticals Reports Underwhelming Data From Inherited Disease Study
Benzinga via Yahoo Finance· 1 year agoTakeda Pharmaceutical Co Ltd (NYSE: TAK) and Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR) announced...